Omada Health, Inc. OMDA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 43.12% | 42.00% | 58.08% | 49.47% | 48.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.12% | 42.00% | 58.08% | 49.47% | 48.92% |
| Cost of Revenue | 14.16% | 27.28% | 40.01% | 35.43% | 28.62% |
| Gross Profit | 58.26% | 52.64% | 67.00% | 57.80% | 62.30% |
| SG&A Expenses | 31.73% | 29.49% | 29.24% | 32.04% | 33.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.26% | 30.73% | 31.75% | 30.54% | 28.23% |
| Operating Income | 181.70% | 43.06% | 146.21% | 70.52% | 56.72% |
| Income Before Tax | 199.68% | 68.56% | 162.53% | 65.55% | 50.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 199.68% | 68.56% | 162.53% | 65.55% | 50.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 199.68% | 68.56% | 162.53% | 65.55% | 50.33% |
| EBIT | 181.70% | 43.06% | 146.21% | 70.52% | 56.72% |
| EBITDA | 271.46% | 53.66% | 181.21% | 84.18% | 66.25% |
| EPS Basic | 136.70% | 95.60% | 108.57% | 95.35% | 82.71% |
| Normalized Basic EPS | 136.66% | 95.60% | 108.56% | 98.43% | 82.70% |
| EPS Diluted | 133.10% | 95.60% | 107.78% | 95.35% | 82.71% |
| Normalized Diluted EPS | 134.22% | 95.60% | 107.77% | 98.43% | 82.70% |
| Average Basic Shares Outstanding | 171.65% | 615.00% | 630.08% | 640.34% | 187.24% |
| Average Diluted Shares Outstanding | 191.05% | 615.00% | 703.95% | 640.34% | 187.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |